TABLE 3.
Reference | Eligibility criteria specified (Yes/No) | Random allocation (0/1) | Concealed allocation (0/1) | Comparable at baseline (0/1) | Blinded subjects (0/1) | Blinded therapists (0/1) | Blinded assessors (0/1) | Adequate follow‐up (0/1) | Intention‐totreat analysis (0/1) | Between group comparisons (0/1) | Point estimates and variability (0/1) | Summary |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fleming et al. (2017) | Yes | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 7 |
Long et al. (2018) | Yes | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
Taud et al. (2021) | Yes | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
Cai (2020) | Yes | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
Cao et al. (2022) | Yes | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 6 |
Ren et al. (2018) | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5 |
Hsu et al. (2021) | Yes | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
Kim (2021) | Yes | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
Lindenberg et al. (2010) | Yes | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 6 |
Ji (2014) | Yes | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |